Generation Bio Co.
GBIO
$0.33
-$0.013-3.79%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 108.29% | -44.56% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 108.29% | -44.56% | |||
| Cost of Revenue | -3.73% | 2.89% | |||
| Gross Profit | 62.27% | -86.18% | |||
| SG&A Expenses | 0.94% | -0.66% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.38% | 1.08% | |||
| Operating Income | 23.96% | -21.70% | |||
| Income Before Tax | 30.77% | -39.63% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 30.77% | -39.63% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 30.77% | -39.63% | |||
| EBIT | 23.96% | -21.70% | |||
| EBITDA | 25.22% | -23.37% | |||
| EPS Basic | 30.99% | -39.54% | |||
| Normalized Basic EPS | 24.96% | -28.23% | |||
| EPS Diluted | 30.99% | -39.54% | |||
| Normalized Diluted EPS | 24.96% | -28.23% | |||
| Average Basic Shares Outstanding | 0.32% | 0.08% | |||
| Average Diluted Shares Outstanding | 0.32% | 0.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||